Aptargroup, Inc.

Industry

  • Services
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
      • Pulmonary
      • Nasal
    • OTC, Consumer
  • Medical Devices
  • Contract Research Organization-CRO

Other Names/Subsidiaries

  • Aptar pharma
  • Noble International, Inc.
See more in Biomedtracker

Latest on Aptargroup, Inc.

Medtech Insight

Pacts In Medtech: BI, Inflammasome Work On Retinal Disease; Takeda And Prometheus Take On IBD

 
• By Reed Miller

Deals In September BI, Inflammasome Ally In $160m Retinal Diseases Collaboration Boehringer Ingelheim International GmbH and Inflammasome Therapeutics Inc. agreed to co-develop up to three candida

Scrip

Lupin-Aptar Launch India’s First Smart Device For MDIs At $22 Apiece

 
• By Vibha Ravi

With an eye on the rising number of tech-savvy patients and health care personnel (HCP) relying on digital information, Lupin Ltd. has partnered with Aptar Pharma to introduce India’s first smart

Scrip

Venture Funding Deals: Tenaya's $92m, Nuvation's $275m Lead October Rounds

 
• By Deanna Kamienski, Beth Allan, and Maureen Riordan

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharma

Pink Sheet

Keeping Track: US FDA Clears Two More Biosimilars, First Non-Injectable Glucagon

 
• By Michael Cipriano

On the heels of Amgen Inc. and Allergan PLC launching the first two oncology biosimilars in the US, the US Food and Drug Administration approved a pair of new biosimilars just days later: Pfizer